Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. National Institutes of Health (...) software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Randomized Controlled Trial Am J Respir Crit Care Med Actions . 2021 Jan 15;203(2):202-210. doi: 10.1164/rccm.202004-1201OC. Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand

Guidance for contacts of people with confirmed coronavirus (COVID-19) infection who do not live with the person Guidance for contacts of people with confirmed coronavirus (COVID-19) infection who do not live with the person - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance (...) and support Guidance Guidance for contacts of people with confirmed coronavirus (COVID-19) infection who do not live with the person Guidance for contacts of a person with a positive test result for coronavirus (COVID-19) who do not live with that person. Published 28 May 2020 Last updated 17 June 2020 — From: Documents HTML Details This guidance is for people who have been notified by NHS Test and Trace that they are a contact of a person who has had a positive test result for coronavirus (COVID-19

COVID-19: infection prevention and control (IPC) Wuhan novel coronavirus: infection prevention and control - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Wuhan novel coronavirus: infection prevention and control Guidance on infection prevention and control for Wuhan novel (...) coronavirus. Published 10 January 2020 Last updated 15 January 2020 — From: Documents HTML Details This guidance outlines infection control for healthcare providers assessing possible cases of WN-CoV. It should be used in conjunction with local policies. In the absence of effective drugs or a vaccine, control of this virus relies on the prompt identification, appropriate risk assessment, management and isolation of possible and confirmed cases, and the investigation and follow up of close contacts

A., Schiffman Z., et al. Predicting infectious SARS-CoV-2 from diagnostic samples. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa638. - - - Bohn M.K., Loh T.P., Wang C.B., Mueller R., Koch D., Sethi S., Rawlinson W.D., Clementi M., Erasmus R., Lepotier M., et al. IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2. Clin. Chem. Lab. Med. 2020;58:2001–2008. doi: 10.1515/cclm-2020-1413. - - Show all 31 references Related information LinkOut - more resources Full Text Sources (...) Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation

Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily (...) new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Clinical Trial Am J Gastroenterol Actions . 2020 Nov;115(11):1802-1811. doi: 10.14309/ajg.0000000000000926. Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients

A Reevaluation of the Risk of Infection Based on Time to Debridement in Open Fractures: Results of the GOLIATH Meta-Analysis of Observational Studies and Limited Trial Data A Reevaluation of the Risk of Infection Based on Time to Debridement in Open Fractures: Results of the GOLIATH Meta-Analysis of Observational Studies and Limited Trial Data - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History (...) at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation J Bone Joint Surg Am Actions . 2021 Feb 3;103(3):265-273. doi: 10.2106/JBJS.20.01103. A Reevaluation of the Risk of Infection Based on Time to Debridement in Open

Efficacy and safety of OM-85 in paediatric recurrent respiratory tract infections which could have a possible protective effect on COVID-19 pandemic: A meta-analysis Efficacy and safety of OM-85 in paediatric recurrent respiratory tract infections which could have a possible protective effect on COVID-19 pandemic: A meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other (...) tract infections which could have a possible protective effect on COVID-19 pandemic: A meta-analysis , , , , , , Affiliations Expand Affiliations 1 Department of Pediatrics, The First Hospital of Lanzhou University, Lanzhou, P.R. China. 2 Division of Rheumatology & Allergy in the Department of Pediatrics, the First Hospital of Jilin University, Changhun, Jilin, P.R. China. 3 Department of Pediatrics, The General Hospital of Ningxia Medical University, Yinchuan, P.R. China. 4 Clinical Pharmacy

Ultrasound gel: good infection prevention practice Ultrasound gel: good infection prevention practice - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Show or hide search Search on GOV.UK Search Menu National lockdown: stay at home Check how the new rules affect you Guidance Ultrasound gel (...) : good infection prevention practice This is interim guidance on the safe use of ultrasound gel to reduce risk of transmission of infection during ultrasound and related procedures. Published 15 January 2021 From: Documents Ref: PHE publications reference number GW-1865 HTML Ref: PHE publications gateway number GW-1865 PDF , 118KB , 3 pages This file may not be suitable for users of assistive technology. Request an accessible format. If you use assistive technology (such as a screen reader) and need

Post-operative wound care: reducing the risk of surgical site infection

at risk for this often-fatal infection Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Ebola vaccine rVSV-Zebov (Ervebo°) in an outbreak of Ebola virus disease. Major reduction in incidence among those at risk for this often-fatal infection FEATURED REVIEW Ebola virus disease is a contagious and often fatal infection for which there was no vaccine (...) Ebola vaccine rVSV-Zebov (Ervebo) in an outbreak of Ebola virus disease. Major reduction in incidence among those at risk for this often-fatal infection Prescrire IN ENGLISH - Spotlight ''Ebola vaccine rVSV-Zebov (Ervebo°) in an outbreak of Ebola virus disease. Major reduction in incidence among those at risk for this often-fatal infection'', 1 February 2021 {1} {1} {1} | | > > > Ebola vaccine rVSV-Zebov (Ervebo°) in an outbreak of Ebola virus disease. Major reduction in incidence among those

Real-life validation of the Panbio COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features (...) subjects with symptoms of potential SARS-CoV-2 infection , , , , , , , , , Affiliations Expand Affiliations 1 Department of Medical Microbiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands. 2 LABHOH, Fundacion Servicio Medico Laboratorio Aruba, Dr. Horacio E. Oduber Hospital, Boulevard 1, Oranjestad, Aruba. 3 GGD regio Utrecht, De Dreef 5, 3706 BR Zeist, the Netherlands. 4 Dr. Horacio E. Oduber Hospital, Boulevard 1, Oranjestad, Aruba. PMID: 33521610 PMCID

Tenofovir alafenamide for treating chronic hepatitis B infection '); } else { document.write(' '); } ACE | Tenofovir alafenamide for treating chronic hepatitis B infection Search > > Tenofovir alafenamide for treating chronic hepatitis B infection - Tenofovir alafenamide for treating chronic hepatitis B infection Published on 18 January 2021 Guidance Recommendations The Ministry of Health’s Drug Advisory Committee has not recommended listing tenofovir alafenamide (TAF) on the Medication (...) Assistance Fund (MAF) for treating chronic hepatitis B infection, due to unfavourable cost-effectiveness compared with tenofovir disoproxil fumarate (TDF) at the price proposed by the manufacturer. Quicklinks | | | | | © 2020 Ministry of Health, Singapore Last updated on 18 January 2021

Center for Musculoskeletal Infections, University Hospital Basel, Basel, Switzerland. 2 Department of Orthopaedic and Trauma Surgery, University Hospital Basel, Basel, Switzerland. 3 Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland. 4 Keck School of Medicine, University of Southern California, LAC+USC Medical Center, Los Angeles, California, USA. 5 The Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals, Oxford, UK. 6 (...) Surgery, University Hospital Basel, Basel, Switzerland. 3 Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland. 4 Keck School of Medicine, University of Southern California, LAC+USC Medical Center, Los Angeles, California, USA. 5 The Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals, Oxford, UK. 6 Interdisciplinary Unit for Orthopaedic Infections, Kantonsspital Baselland, Liestal, Switzerland. 7 KU Leuven Libraries

Systematic Review and Meta-Analysis of Wound Adjuncts for the Prevention of Groin Wound Surgical Site Infection in Arterial Surgery Systematic Review and Meta-Analysis of Wound Adjuncts for the Prevention of Groin Wound Surgical Site Infection in Arterial Surgery - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 (...) Site Infection in Arterial Surgery , , , , , , , , , , , , , Affiliations Expand Affiliations 1 South East Wales Vascular Network, Royal Gwent Hospital, Newport, UK. Electronic address: https://twitter.com/VascResearchNet. 2 University of Bristol, Bristol, UK. 3 Queen Elizabeth Hospital Birmingham, Birmingham, UK. 4 Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UK; Academic Section of Vascular Surgery, Department of Surgery & Cancer, Imperial College London, London, UK. 5

Leukomed Sorbact for preventing surgical site infection Leukomed Sorbact for preventing surgical site infection Medical technologies guidance Published: 3 February 2021 www.nice.org.uk/guidance/mtg55 © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising (...) discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Leukomed Sorbact for preventing surgical site infection (MTG55) © NICE 2021. All rights

The VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to heal The VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to heal Medical technologies guidance Published: 27 January 2021 www.nice.org.uk/guidance/mtg54 © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility This guidance represents the view of NICE, arrived (...) . The VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to heal (MTG54) © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 22Contents Contents 1 Recommendations 4 2 The technology 6 T echnology 6 Innovative aspects 6 Intended use 7 Costs 7 3 Evidence 8 Clinical evidence 8 Cost evidence 11 4 Committee discussion 14 Clinical-effectiveness overview 14 Relevance to the NHS 15 Outcome

is advised, except in mild infections that were induced by antibiotic use. It strongly recommends FMT for multiple recurrent C. difficile infection. • Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Recommends FMT for people with multiple recurrences of C. difficile infection when appropriate antibiotic treatments have not worked. Faecal (...) Faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection Faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection Medtech innovation briefing Published: 2 February 2021 www.nice.org.uk/guidance/mib247 pathways Summary Summary • The procedure procedure described in this briefing is faecal microbiota transplant (FMT). It is used to treat recurrent or refractory Clostridioides difficile (C.difficile; formerly Clostridium

Reliability of nonlocalizing signs and symptoms as indicators of the presence of infection in nursing-home residents Reliability of nonlocalizing signs and symptoms as indicators of the presence of infection in nursing-home residents Search Search Search Search Reliability of nonlocalizing signs and symptoms as indicators of the presence of infection in nursing-home residents Extract Antibiotics are among the most common medications prescribed in nursing homes. The annual prevalence (...) of antibiotic use in residents of nursing homes ranges from 47% to 79%, and more than half of antibiotic courses initiated in nursing-home settings are unnecessary or prescribed inappropriately (wrong drug, dose, or duration). Inappropriate antibiotic use is associated with a variety of negative consequences including Clostridioides difficile infection (CDI), adverse drug effects, drug–drug interactions, and antimicrobial resistance. In response to this problem, public health authorities have called

COVID-19: guidance for stepdown of infection control precautions within hospitals and discharging COVID-19 patients from hospital to home settings COVID-19: guidance for stepdown of infection control precautions within hospitals and discharging COVID-19 patients from hospital to home settings - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve (...) accepted all cookies. You can at any time. Hide Search Stay at home Only go outside for food, health reasons or work (but only if you cannot work from home) If you go out, stay 2 metres (6ft) away from other people at all times Wash your hands as soon as you get home Do not meet others, even friends or family. You can spread the virus even if you don’t have symptoms. Guidance COVID-19: guidance for stepdown of infection control precautions within hospitals and discharging COVID-19 patients from

of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection , , , , , , , , , Affiliations Expand Affiliations 1 Department of Medical Laboratory Center, General Hospital of Central Theater Command, Wuhan, China. 2 Microbiome Medicine Center, Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China. 3 Institute of Immunology, PLA, Third Military Medical University, Chongqing, China. 4 Department of Infectious Diseases, Southwest Hospital, Third (...) Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information